{
    "clinical_study": {
        "@rank": "23372", 
        "arm_group": [
            {
                "arm_group_label": "CBT- based SMS text messaging intervention", 
                "arm_group_type": "Experimental", 
                "description": "cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention"
            }, 
            {
                "arm_group_label": "Placebo Texts", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo texts will be given instead of interventional texts"
            }
        ], 
        "brief_summary": {
            "textblock": "This Phase I behavior therapy development study seeks to improve treatment outcomes for\n      methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy-\n      (CBT-) based short message service (SMS) text messaging intervention."
        }, 
        "brief_title": "A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence", 
        "condition": "Amphetamine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Amphetamine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  English-speaking adults \u2265 18 years who are seeking treatment for MA addiction.\n\n          -  Own a cellular phone with SMS text messaging capability and have an unlimited text\n             messaging plan.\n\n          -  Available to attend CBT therapy groups.\n\n          -  Agreeable to conditions of the study and signed an informed consent form.\n\n        Exclusion Criteria:\n\n          -  Projected to be unavailable > 12 hours/day to read and send text messages.\n\n          -  Any medical or psychosocial condition that would preclude safe, useful, or consistent\n             participation,"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899313", 
            "org_study_id": "2012.119-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "CBT- based SMS text messaging intervention", 
                "intervention_name": "CBT- based SMS text messaging intervention", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "CBT- based SMS text messaging intervention", 
                    "Placebo Texts"
                ], 
                "intervention_name": "CBT group therapy", 
                "intervention_type": "Behavioral", 
                "other_name": "Cognitive Behavioral Group Therapy"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methamphetamine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "methamphetamine dependence", 
            "texting", 
            "short message service", 
            "addiction", 
            "amphetamine", 
            "outpatient"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "link": {
            "description": "clinical site at which patients are seen", 
            "url": "http://nltc.com/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "garrisk@cpmcri.org", 
                    "last_name": "Kathleen Garrison", 
                    "phone": "415-600-1652"
                }, 
                "facility": {
                    "address": {
                        "city": "Lafayette", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94549"
                    }, 
                    "name": "New Leaf Treatment Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "garrisk@cpmcri.org", 
                    "last_name": "Kathleen Garrison", 
                    "phone": "415-600-1652"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94107"
                    }, 
                    "name": "Addiction & Pharmacology Research Laboratory"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence", 
        "overall_contact": {
            "email": "garrisk@cpmcri.org", 
            "last_name": "Kathleen Garrison", 
            "phone": "415-600-3126"
        }, 
        "overall_contact_backup": {
            "email": "palrx@cpmcri.org", 
            "last_name": "Reshmi Pal", 
            "phone": "415-600-1652"
        }, 
        "overall_official": {
            "affiliation": "California Pacific Medical Center", 
            "last_name": "Gantt Galloway, PharmD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary efficacy measure for this study is the difference in proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period. Urine samples will be analyzed for MA by immunoassay with a cutoff of 1,000 ng/mL.", 
            "measure": "Proportion of MA-negative urine samples between the 2-week CBT text period and the 2-week control period", 
            "safety_issue": "No", 
            "time_frame": "5 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899313"
        }, 
        "responsible_party": {
            "investigator_affiliation": "California Pacific Medical Center Research Institute", 
            "investigator_full_name": "Gantt Galloway, PharmD", 
            "investigator_title": "Senior Scientist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "California Pacific Medical Center Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "California Pacific Medical Center Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}